scispace - formally typeset
Journal ArticleDOI

Cannabinoids in treatment-resistant epilepsy: A review.

Brooke K. O'Connell, +2 more
- 01 May 2017 - 
- Vol. 70, Iss: 70, pp 341-348
TLDR
Open-label studies with 100mg/ml CBD have provided additional evidence of its efficacy along with an adequate safety profile in children and young adults with a spectrum of TREs and Phase 3 RCTs with Epidiolex support efficacy and adequate safety profiles for children with DS and LGS.
About
This article is published in Epilepsy & Behavior.The article was published on 2017-05-01. It has received 162 citations till now. The article focuses on the topics: Cannabis & Cannabidiol.

read more

Citations
More filters
Journal ArticleDOI

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?

TL;DR: In this paper, a review highlights some contributions from Brazilian researchers and other studies reported elsewhere on the history, pre-clinical and clinical data underlying the use of cannabinoids for the already widespread treatment of refractory epilepsies and the possibility of use in the treatment of some neuropsychiatric disorders.
Journal ArticleDOI

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations

TL;DR: A systematic review of economic evaluations of cannabis-based products and other pharmacologic treatments for pediatric drug-resistant epilepsy, as well as resource utilization and utility studies, to inform decision-making by public healthcare payers about reimbursement of such products.
Journal ArticleDOI

An assessment of the potency related to Cannabis-based products in the South African market

TL;DR: In this article, the authors analyse a portion of the South African cannabis-based products market and provide a detailed overview of their THC and CBD profiles, showing that high amounts of THC are present in most of the products in South Africa.
Journal ArticleDOI

Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury

TL;DR: In this article, the authors proposed a dual therapy by targeting the site of injury internally with a CBD-infused medical carrier followed by systemic supplementation may offer a more effective countermeasure than systemic or implant treatment alone for the deleterious effects of penetrating head wounds.
Book ChapterDOI

Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

TL;DR: In this paper, the authors summarized the current knowledge on the pharmacokinetics and metabolic fate of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) in humans and discussed relevant drug-drug interactions.
References
More filters
Journal ArticleDOI

Early Identification of Refractory Epilepsy

TL;DR: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.
Journal ArticleDOI

Adverse Health Effects of Marijuana Use

TL;DR: As marijuana use becomes legal in some states, the dominant public opinion is that marijuana is a harmless source of mood alteration, but enough information is available to cause concern.
Related Papers (5)